Synopsis
Motivation:
Goals:
Approach:
Results:
631-03-002 / 631-03-002
ISMRM Abstract
Time-dependent Diffusion MRI Differentiates Atypical from Conventional Uterine Leiomyomas: A Preliminary Study
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Tu W, Yano M, Schieda N, Krishna S, Chen L, Gottumukkala RV, Alencar R. Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification. Radiographics. 2023;43(6):e220161. doi: 10.1148/rg.220161. [doi]
2. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3–11. doi: 10.1016/j.bpobgyn.2017.09.004. [doi]
3. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004;159(2):113–123. doi: 10.1093/aje/kwh016. [doi]
4. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512. doi: 10.1111/1471-0528.14640. [doi]
5. Tamehisa T, Sato S, Sakai T, Maekawa R, Tanabe M, Ito K, Sugino N. Establishment of Noninvasive Prediction Models for the Diagnosis of Uterine Leiomyoma Subtypes. Obstet Gynecol. 2024;143(3):358–365. doi: 10.1097/AOG.0000000000005475. [doi]
6. Tasaki A, Asatani MO, Umezu H, et al. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density. Abdom Imaging. 2015;40(6):1742–1752. doi: 10.1007/s00261-014-0324-5. [doi]
7. Schwartz LB, Zawin M, Carcangiu ML, Lange R, McCarthy S. Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril. 1998;70(3):580–587. doi: 10.1016/S0015-0282(98)00193-9. [doi]
8. Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189(3):721–725. doi: 10.1148/radiology.189.3.8234695. [doi]
9. Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408. doi: 10.1002/ijgo.12666. [doi]
10. Iima M, Honda M, Sigmund EE, Ohno Kishimoto A, Kataoka M, Togashi K. Diffusion MRI of the breast: Current status and future directions. J Magn Reson Imaging. 2020;52(1):70–90. doi: 10.1002/jmri.26908. [doi]
11. Jia Y, Song G, Wu R, Hong Y, Dou W, Li A. Intravoxel incoherent motion DWI with different mathematical models in predicting rectal adenoma with and without canceration. Eur J Radiol. 2022;155:110496. doi: 10.1016/j.ejrad.2022.110496. [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/631-03-002